13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-14, with 28 holding rows worth $989,267,000.
- Accession
- 0001144204-14-050172
- Filer
- CIK 1346824
- Filed
- 2014-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2014
A holdings report, 28 entries on the cover page, a total value of $989,267,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $989,267,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 22,486,007 | $170,219,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 5,250,000 | $118,598,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| DYAX CORP | 26746E103 | COM | 9,982,578 | $95,833,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 6,000,000 | $91,620,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,539,586 | $66,310,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $54,813,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| VERSARTIS INC | 92529L102 | COM | 1,203,002 | $50,107,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 2,791,305 | $42,623,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,198,529 | $40,781,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 4,869,261 | $31,748,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| NOVAVAX INC | 670002104 | COMMON STOCK | 6,661,731 | $30,777,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 3,000,000 | $22,710,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 14,036,590 | $22,459,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| OPHTHOTECH CORP | 683745103 | COM | 527,941 | $22,337,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| REPROS THERAPEUTICS INC | 76028H209 | COM | 1,219,381 | $21,095,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| BLUEBIRD BIO INC | 09609G100 | COM | 503,062 | $19,403,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| THERAPEUTICSMD INC | 88338N107 | COM | 4,303,066 | $19,020,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 597,363 | $16,601,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,016,735 | $11,814,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| PSIVIDA CORP | 74440J101 | COM | 2,555,659 | $11,092,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 604,346 | $8,648,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 840,000 | $6,737,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ALIMERA SCIENCES INC | 016259103 | COM | 666,667 | $3,987,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 490,697 | $3,749,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| IMMUNOMEDICS INC | 452907108 | COM | 1,000,000 | $3,650,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| OXYGEN BIOTHERAPEUTICS INC | 69207P308 | COM PAR $0.0001 | 315,298 | $1,286,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 68,968 | $1,023,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| PRANA BIOTECHNOLOGY LTD | 739727105 | SPONSORED ADR | 100,000 | $227,000 | thousands by filing date | callThe filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-14-050172 | this filing | 2014-08-14 | acceptance time not in the bulk data set |